Jeff Yass’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$37.4K Buy
+13,600
New +$41.2K ﹤0.01% 12983
2026
Q2
– Sell
-51,100
Closed -$213K – 13456
2026
Q1
$213K Buy
+51,100
New +$216K ﹤0.01% 11562

Other funds holding CATX

Jeff Yass's CATX Position: Q3 2026 in Review

Jeff Yass increased its Perspective Therapeutics (CATX) stake by 187% in Q3 2026, buying an estimated $169K and bringing the position to 85,368 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #11555.

Jeff Yass first reported a position in CATX in Q2 2014 and has held it in 29 quarters since. The position peaked at $778K in Q1 2026. 120 funds tracked by Wall St. Rank hold CATX as of Q3 2026.

  • Jeff Yass held 85,368 shares of Perspective Therapeutics worth $235K as of Q3 2026.
  • Jeff Yass bought 55,579 Perspective Therapeutics shares in Q3 2026, an estimated $169K.
  • Perspective Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11555 holding.
  • Jeff Yass first reported a position in Perspective Therapeutics in Q2 2014 and has held it in 29 quarters since.
  • Jeff Yass's Perspective Therapeutics position peaked at $778K in Q1 2026.
  • 120 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.